Akoya Biosciences Inc (AKYA) Stock
AKYA is no longer traded. Akoya Biosciences was delisted from the Nasdaq in July 2025.
Prices on this page are historical; the last trade was July 7, 2025 at $1.29.
Akoya Biosciences stock price history
AKYA final trading statistics
- Final close
- $1.29
- Final trading day
- Jul 7, 2025
- Market cap at delisting
- $64.44M
- Shares outstanding
- 49.95M
- Final 52-week range
- $0.93 – $3.42
- Avg. volume (final 3 mo.)
- 574,563
- All-time high (split-adj.)
- $26.05 · Apr 2021
- All-time low (split-adj.)
- $0.95 · May 2025
- Return since IPO
- -95.0%
- Beta
- 1.35
- Book value / share
- -$0.12
- Price / book
- -10.93
Akoya Biosciences annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $81.67M | -$55.4M | -$1.10 |
| FY2023 | $96.63M | -$63.3M | -$1.43 |
| FY2022 | $74.86M | -$70.6M | -$1.88 |
| FY2021 | $54.92M | -$42.9M | -$4.52 |
| FY2020 | $42.44M | -$16.7M | -$0.20 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Akoya Biosciences Inc
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Akoya Biosciences stock FAQ
What happened to Akoya Biosciences stock?
Akoya Biosciences stock was delisted from the Nasdaq. Its final close was $1.29 on July 7, 2025.
Is AKYA stock still trading?
No. AKYA was delisted from the Nasdaq in July 2025 and no longer trades on a U.S. exchange.
What was the last price of AKYA stock?
AKYA closed at $1.29 on its final trading day, July 7, 2025, for a market value of about $64.44M.
What were Akoya Biosciences's revenue and earnings in its last full fiscal year?
Akoya Biosciences reported revenue of $81.67M and net income of -$55.4M in fiscal 2024, its last full year as a public company.
When did Akoya Biosciences go public?
Akoya Biosciences Inc stock began trading on April 16, 2021.